Science Corporation implants its vision-restoring chip in its first Stargardt disease patient

AI Summary

Science Corporation has successfully implanted its PRIMA vision-restoring chip in its first patient with Stargardt disease, a genetic eye disorder that causes progressive vision loss. Max Hodak, former Neuralink president and co-founder, revealed at TechCrunch Disrupt that this implant work is part of the company's broader development toward creating a novel brain-computer interface.